These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 8547469)
41. Variable tolerance of the developing follicle and corpus luteum to gonadotropin-releasing hormone antagonist-induced gonadotropin withdrawal in the human. Hall JE; Bhatta N; Adams JM; Rivier JE; Vale WW; Crowley WF J Clin Endocrinol Metab; 1991 May; 72(5):993-1000. PubMed ID: 1902489 [TBL] [Abstract][Full Text] [Related]
42. The depot GnRH analogue goserelin in the treatment of premenopausal patients with metastatic breast cancer--a 5-year experience and further endocrine therapies. Cooperative German Zoladex Study Group. Kaufmann M; Jonat W; Schachner-Wünschmann E; Bastert G; Maass H Onkologie; 1991 Feb; 14(1):22-4, 26-8, 30. PubMed ID: 1829149 [TBL] [Abstract][Full Text] [Related]
43. Oral contraceptive therapy for polycystic ovary disease after chronic gonadotropin-releasing agonist administration. Predictors of continued ovarian suppression. Elkind-Hirsch KE; Anania C; Malinak R J Reprod Med; 1996 Sep; 41(9):645-52. PubMed ID: 8887188 [TBL] [Abstract][Full Text] [Related]
44. Correlation between integrated LH and FSH levels and the response to luteinizing hormone relasing factor (LRF). Mortimer RH; Fleischer N; Lev-Gur M; Freeman RG J Clin Endocrinol Metab; 1976 Dec; 43(6):1240-9. PubMed ID: 794076 [TBL] [Abstract][Full Text] [Related]
45. The rapid ovarian secretory response to pituitary stimulation by the gonadotropin-releasing hormone agonist nafarelin in sexual precocity. Rosenfield RL; Garibaldi LR; Moll GW; Watson AC; Burstein S J Clin Endocrinol Metab; 1986 Dec; 63(6):1386-9. PubMed ID: 2946712 [TBL] [Abstract][Full Text] [Related]
46. Gonadotropin, steroid, and thyroid hormone milieu of young SWR mice bearing spontaneous granulosa cell tumors. Beamer WG J Natl Cancer Inst; 1986 Nov; 77(5):1117-23. PubMed ID: 3095581 [TBL] [Abstract][Full Text] [Related]
47. [Appropriate prolongation of GnRH-a down-regulation improves the synchronism of follicular development]. Wang B; Sun HX; Liu JY; Hu YL; He FF Zhonghua Nan Ke Xue; 2011 Dec; 17(12):1087-91. PubMed ID: 22235676 [TBL] [Abstract][Full Text] [Related]
48. Luteinizing hormone release after administration of the gonadotropin-releasing hormone agonist Fertilan (goserelin) for synchronization of ovulation in pigs. Brüssow KP; Schneider F; Tuchscherer A; Rátky J; Kraeling RR; Kanitz W J Anim Sci; 2007 Jan; 85(1):129-37. PubMed ID: 17179548 [TBL] [Abstract][Full Text] [Related]
49. Gonadal protection by a gonadotropin-releasing hormone agonist depot in young women with Hodgkin's disease undergoing chemotherapy. Franke HR; Smit WM; Vermes I Gynecol Endocrinol; 2005 May; 20(5):274-8. PubMed ID: 16019373 [TBL] [Abstract][Full Text] [Related]
50. Gonadotropin and alpha-subunit responses to chronic gonadotropin-releasing hormone analog administration in patients with glycoprotein hormone-secreting pituitary tumors. Klibanski A; Jameson JL; Biller BM; Crowley WF; Zervas NT; Rivier J; Vale WW; Bikkal H J Clin Endocrinol Metab; 1989 Jan; 68(1):81-6. PubMed ID: 2535852 [TBL] [Abstract][Full Text] [Related]